The New York Ear and Eye Infirmary recently published a study showing Diopsys NOVA-LX Visual Evoked Potential Vision Testing System to be an effective tool in the early detection of glaucoma.
The Diopsys NOVA-LX is designed to use high and low contract checks to test the entire vision system's function.
Robert Ritch, MD, the chief of glaucoma service and surgeon director at New York Eye and Ear Infirmary, authored the study.
More Articles on Ophthalmology:
Dr. Christopher Calvin Brown Joins San Antonio Eye Center
Bausch + Lomb Files for Public Offering to Meet $700M Financial Obligation
Dr. Gholman Peyman Joins Insite Vision
The Diopsys NOVA-LX is designed to use high and low contract checks to test the entire vision system's function.
Robert Ritch, MD, the chief of glaucoma service and surgeon director at New York Eye and Ear Infirmary, authored the study.
More Articles on Ophthalmology:
Dr. Christopher Calvin Brown Joins San Antonio Eye Center
Bausch + Lomb Files for Public Offering to Meet $700M Financial Obligation
Dr. Gholman Peyman Joins Insite Vision